Cross Country Healthcare (CCRN) Other financing activities (2010 - 2023)

Cross Country Healthcare has reported Other financing activities for 12 years, with the latest figure at -$501000.0 in Q2 2023.

• For the quarter ending Q2 2023, Other financing activities rose 86.14% year-over-year to -$501000.0; the trailing twelve-month figure through Mar 2024 stood at -$501000.0 (down 463.04% YoY), and the FY2023 full-year result was -$508000.0, down 115.69% from the prior year.
• Other financing activities for Q2 2023 stood at -$501000.0, down from -$7000.0 in the prior quarter.
• The five-year high for Other financing activities was $4.3 million in Q2 2021, with the low at -$4.8 million in Q4 2021.
• Historically, Other financing activities has averaged $120111.1 across 5 years, with a median of -$8500.0 in 2020.
• The largest YoY upside for Other financing activities was 43250.0% in 2021 against a maximum downside of 7200.0% in 2021.
• Cross Country Healthcare's Other financing activities stood at $1.5 million in 2019, then sank by 95.48% to $68000.0 in 2020, then tumbled by 7200.0% to -$4.8 million in 2021, then jumped by 178.15% to $3.8 million in 2022, then plunged by 113.28% to -$501000.0 in 2023.
• The last three Other financing activities figures came in at -$501000.0 (Q2 2023), -$7000.0 (Q1 2023), and $3.8 million (Q4 2022), per Business Quant data.